Spyre Therapeutics (SYRE) Revenue (2015 - 2023)
Spyre Therapeutics' (SYRE) quarterly Revenue came in at $688000.0 in Q2 2023, up 10.08% YoY from $625000.0 in Q2 2022, and up 247.47% on a QoQ basis from $198000.0 in Q1 2023.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Revenue (2015 - 2023) Analysis & Trends
Spyre Therapeutics (SYRE) has 7 years of Revenue data on file, last reported at $688000.0 in Q2 2023.
- Quarterly Revenue rose 10.08% year-over-year to $688000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $688000.0 (down 40.94% YoY) and the FY2023 annual result came in at $886000.0, down 61.96% from the prior year.
- Revenue improved to $688000.0 in Q2 2023, from $198000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $13.7 million in Q2 2021 to a low of $168000.0 in Q4 2022.
- A 3-year average of $3.6 million and a median of $688000.0 in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue slumped 98.55% — and 2023, when it rose 10.08%.
- Tracing SYRE's Revenue over 3 years: stood at $3.6 million in 2021, then sank by 95.39% to $168000.0 in 2022, then surged by 309.52% to $688000.0 in 2023.
- The last three Revenue figures came in at $688000.0 (Q2 2023), $198000.0 (Q1 2023), and $168000.0 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Spyre Therapeutics | 7.53 Bn | 7.53 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 688,000.00 |
| Mar 31, 2023 | 198,000.00 |
| Dec 31, 2022 | 168,000.00 |
| Sep 30, 2022 | 174,000.00 |
| Jun 30, 2022 | 625,000.00 |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 3.64 Mn |
| Sep 30, 2021 | 12.00 Mn |
| Jun 30, 2021 | 13.70 Mn |
| Jun 30, 2018 | 2.38 Mn |
| Mar 31, 2018 | 1.51 Mn |
| Dec 31, 2017 | 1.48 Mn |
| Sep 30, 2017 | 1.26 Mn |
| Jun 30, 2017 | 1.48 Mn |
| Mar 31, 2017 | 982,000.00 |
| Dec 31, 2016 | 1.25 Mn |
| Sep 30, 2016 | 1.15 Mn |
| Jun 30, 2016 | 1.37 Mn |
| Mar 31, 2016 | 859,000.00 |
| Dec 31, 2015 | 1.59 Mn |